Saaby Lasse, Helms Hans Christian Cederberg, Brodin Birger
Bioneer-FARMA, Department of Pharmacy, Universitetsparken 2 , DK-2100 Copenhagen, Denmark.
Section of Pharmaceutical Design and Drug Delivery, Department of Pharmacy, Universitetsparken 2 , DK-2100 Copenhagen, Denmark.
Mol Pharm. 2016 Feb 1;13(2):640-52. doi: 10.1021/acs.molpharmaceut.5b00874. Epub 2016 Jan 5.
The P-glycoprotein (P-gp) efflux pump has been shown to affect drug distribution and absorption in various organs and to cause drug resistance in cancer therapy. The aim of this work was to develop a cell line to serve as a screening system for potential substrates of P-gp. This requires a cell line with high paracellular tightness, low expression of nonhuman ABC transporters, and high expression of functional human P-gp (ABCB1). The porcine intestinal epithelial cell line, IPEC-J2, was selected as a transfection host, due to its ability to form extremely high-resistance monolayers (>10,000 Ω·cm(2)) and its low endogenous expression of ABC-type efflux transporters. The IPEC-J2 cells were transfected with a plasmid that contained the sequence of the human MDR1 gene, which encodes P-gp, followed by a selection of successfully transfected cells with geneticin and puromycin. The resulting cell line, IPEC-J2 MDR1, retained its high transepithelilal resistance (>15,000 Ω·cm(2)), which translated into low permeability of the small hydrophilic tracer, mannitol (P < 10(-7) cm·s(-1)). The lipophilic compound, diazepam, displayed high permeability resulting in a dynamic range of 1500 (PDiazepam/Pmannitol) to separate high and low permeability compounds. Human P-gp was expressed predominantly in the apical membrane, as demonstrated by immunocytochemistry, Western blots, and a high efflux ratios (Pbasolateral-apical/Papical-basolateral) of known P-gp substrates. P-gp was demonstrated to be responsible for the efflux transport by substrate profiling, combined with application of P-gp and BCRP inhibitors. Furthermore, the compounds atenolol, citalopram, and mitoxantrone were identified as P-gp substrates. Functional P-gp expression was shown to be stable through at least 10 cell passages. In conclusion, the IPEC-J2 MDR1 cell line displays high paracellular tightness combined with high expression of human P-gp and low expression of porcine ABC transporters, and it may serve as a useful tool in drug development studies.
P-糖蛋白(P-gp)外排泵已被证明会影响药物在各个器官中的分布和吸收,并在癌症治疗中导致耐药性。这项工作的目的是开发一种细胞系,用作P-gp潜在底物的筛选系统。这需要一种具有高细胞旁紧密性、低非人类ABC转运蛋白表达以及功能性人类P-gp(ABCB1)高表达的细胞系。猪肠道上皮细胞系IPEC-J2被选作转染宿主,因为它能够形成极高电阻的单层(>10,000 Ω·cm²),且其ABC型外排转运蛋白的内源性表达较低。用包含编码P-gp的人类MDR1基因序列的质粒转染IPEC-J2细胞,随后用遗传霉素和嘌呤霉素筛选成功转染的细胞。所得细胞系IPEC-J2 MDR1保留了其高跨上皮电阻(>15,000 Ω·cm²),这转化为小分子亲水性示踪剂甘露醇的低渗透性(P < 10⁻⁷ cm·s⁻¹)。亲脂性化合物地西泮显示出高渗透性,导致分离高渗透性和低渗透性化合物的动态范围为1500(P地西泮/P甘露醇)。免疫细胞化学、蛋白质印迹以及已知P-gp底物的高外排比率(P基底外侧-顶端/P顶端-基底外侧)表明,人类P-gp主要在顶端膜表达。通过底物分析,并结合应用P-gp和BCRP抑制剂,证明P-gp负责外排转运。此外,阿替洛尔、西酞普兰和米托蒽醌被鉴定为P-gp底物。功能性P-gp表达至少在10次细胞传代中显示稳定。总之,IPEC-J2 MDR1细胞系表现出高细胞旁紧密性,同时具有人类P-gp的高表达和猪ABC转运蛋白的低表达,它可能是药物开发研究中的一个有用工具。